Lugano, Switzerland, January 11, 2016: Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, is delighted to launch its 40th…

In calling for the “European Year Against Joint Pain”, the European Pain Federation EFIC® is devoting itself this year to an especially widespread…

RESEARCH on the intestine is a rapidly evolving field for a multitude of reasons, not least due to the incredible progress made in the development of…

SIGNATURE 3, a specific genomic molecular fingerprint, represents a fresh avenue of investigation for physicians and researchers aiming to…

PHAGOCYTIC multinucleated giant cells (MGCs) act as the waste disposal men of the body by clearing away bulky waste materials that carry the potential…

SUPPRESSION of group 2 innate lymphoid (IL2) cells following infection has been shown to prevent the innate immune response from continuing when…

SEVEN genetic risk loci have been identified for the ‘atopic march’, the sequential progression of different allergic conditions frequently seen in…

LUGANO/SINGAPORE, 16 December 2015 – ESMO, the leading professional organisation for medical oncology, is pleased to announce the inaugural ESMO Asia…

Seville, Spain – 5 December 2015: Latin American migrants in Spain should be screened for Chagas disease, particularly women before pregnancy…